UniProt ID | T184B_HUMAN | |
---|---|---|
UniProt AC | Q9Y519 | |
Protein Name | Transmembrane protein 184B | |
Gene Name | TMEM184B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 407 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
Protein Description | May activate the MAP kinase signaling pathway.. | |
Protein Sequence | MTVRGDVLAPDPASPTTAAASPSVSVIPEGSPTAMEQPVFLMTTAAQAISGFFVWTALLITCHQIYMHLRCYSCPNEQRYIVRILFIVPIYAFDSWLSLLFFTNDQYYVYFGTVRDCYEALVIYNFLSLCYEYLGGESSIMSEIRGKPIESSCMYGTCCLWGKTYSIGFLRFCKQATLQFCVVKPLMAVSTVVLQAFGKYRDGDFDVTSGYLYVTIIYNISVSLALYALFLFYFATRELLSPYSPVLKFFMVKSVIFLSFWQGMLLAILEKCGAIPKIHSARVSVGEGTVAAGYQDFIICVEMFFAALALRHAFTYKVYADKRLDAQGRCAPMKSISSSLKETMNPHDIVQDAIHNFSPAYQQYTQQSTLEPGPTWRGGAHGLSRSHSLSGARDNEKTLLLSSDDEF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
23 | Phosphorylation | TTAAASPSVSVIPEG CCCCCCCCEEECCCC | 25.24 | - | |
241 | Phosphorylation | FATRELLSPYSPVLK HHHHHHHCCCCHHHH | 34.12 | - | |
244 | Phosphorylation | RELLSPYSPVLKFFM HHHHCCCCHHHHHHH | 16.36 | - | |
334 | Ubiquitination | QGRCAPMKSISSSLK CCCCCCHHHHHHHHH | 43.51 | - | |
335 | Phosphorylation | GRCAPMKSISSSLKE CCCCCHHHHHHHHHH | 22.81 | 28060719 | |
337 | Phosphorylation | CAPMKSISSSLKETM CCCHHHHHHHHHHHC | 22.44 | 30242111 | |
338 | Phosphorylation | APMKSISSSLKETMN CCHHHHHHHHHHHCC | 37.71 | 30242111 | |
339 | Phosphorylation | PMKSISSSLKETMNP CHHHHHHHHHHHCCH | 36.35 | 30576142 | |
341 | Ubiquitination | KSISSSLKETMNPHD HHHHHHHHHHCCHHH | 53.76 | - | |
358 | Phosphorylation | QDAIHNFSPAYQQYT HHHHHHCCHHHHHHH | 17.59 | 26356563 | |
361 | Phosphorylation | IHNFSPAYQQYTQQS HHHCCHHHHHHHHCC | 10.26 | 27642862 | |
364 | Phosphorylation | FSPAYQQYTQQSTLE CCHHHHHHHHCCCCC | 7.32 | 26356563 | |
365 | Phosphorylation | SPAYQQYTQQSTLEP CHHHHHHHHCCCCCC | 18.78 | 26356563 | |
377 | Methylation | LEPGPTWRGGAHGLS CCCCCCCCCCCCCCC | 35.82 | 115918621 | |
384 | Phosphorylation | RGGAHGLSRSHSLSG CCCCCCCCCCCCCCC | 36.01 | 26699800 | |
386 | Phosphorylation | GAHGLSRSHSLSGAR CCCCCCCCCCCCCCC | 17.66 | 27461979 | |
388 | Phosphorylation | HGLSRSHSLSGARDN CCCCCCCCCCCCCCC | 26.02 | 28355574 | |
390 | Phosphorylation | LSRSHSLSGARDNEK CCCCCCCCCCCCCCC | 33.16 | 30108239 | |
397 | Ubiquitination | SGARDNEKTLLLSSD CCCCCCCCEEEECCC | 51.21 | - | |
398 | Phosphorylation | GARDNEKTLLLSSDD CCCCCCCEEEECCCC | 19.23 | 26055452 | |
402 | Phosphorylation | NEKTLLLSSDDEF-- CCCEEEECCCCCC-- | 31.52 | 30266825 | |
403 | Phosphorylation | EKTLLLSSDDEF--- CCEEEECCCCCC--- | 49.39 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of T184B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of T184B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of T184B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SNIP1_HUMAN | SNIP1 | physical | 28514442 | |
RENI_HUMAN | REN | physical | 28514442 | |
CLASR_HUMAN | CLASRP | physical | 28514442 | |
CCDC9_HUMAN | CCDC9 | physical | 28514442 | |
ACINU_HUMAN | ACIN1 | physical | 28514442 | |
SHIP2_HUMAN | INPPL1 | physical | 28514442 | |
NCBP3_HUMAN | C17orf85 | physical | 28514442 | |
YTHD1_HUMAN | YTHDF1 | physical | 28514442 | |
BBS4_HUMAN | BBS4 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-398; SER-402 ANDSER-403, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-402 AND SER-403, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-402 AND SER-403, ANDMASS SPECTROMETRY. |